Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

PrecisionBioticsĀ® (Novonesis) and Biocodex Mark Next Phase of Strategic Partnership with New Agreement

prnewswire.com
NVO

New funding opportunities pave the way for better diagnostics and treatment as well as for engineering efficient biosolutions and replacing critical and scarce resources

globenewswire.com
NVO

Connected Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032: Rising Demand for Telehealth Programs Integrated with AR and Virtual Reality VR Technologies

globenewswire.com
MDT WST MRK NVO TNDM TEVA BDC

ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15'

prnewswire.com
NVO

GLP Diet App Launches Personalized Wellness App for GLP-1 Medication Users, Earns 2,500+ App Reviews

globenewswire.com
NVO LLY

Dry Room Dehumidifier Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2021-2031

globenewswire.com
NVO MU MTX

Novo Nordisk A/S - share repurchase programme

globenewswire.com
NVO

Novo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease

globenewswire.com
NVO

Rebalancing Agents Hympavzi (Pfizer), Qfitlia (Sanofi), Alhemo (Novo Nordisk) Gain Ground in Hemophilia as Physicians Navigate Access Barriers and Expanding Treatment Complexity

globenewswire.com
PFE SNY NVO

China Diabetes Devices Market Forecast and Company Analysis Report 2026-2034 Featuring Roche, Abbott Laboratories, Novo Nordisk, BD, Medtronic, Eli Lilly, and Sanofi

globenewswire.com
ABT NVO BDX MDT LLY SNY